Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Chromosome 17 deletion × Maintenance × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Other hematologic neoplasm 1

Conditions

Uterine Cervical Neoplasms 1 Multiple Myeloma 1 Leukemia, Plasma Cell 1 Chromosome 17 deletion 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

fludarabine phosphate 1 fludarabine 1 Melphalan 1 Maintenance 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04008888 2019-07-05

a Clinical Trial of Efficacy and Safety of the Holistic Treatment of Young High-risk Multiple Myeloma Patients

Institute of Hematology & Blood Diseases Hospital, China

Phase NA Unknown

Other hematologic neoplasmPlasma cell

Chromosome 17 deletion, Leukemia, Plasma Cell, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡